A detailed history of Envestnet Asset Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 2,528,542 shares of GILD stock, worth $227 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,528,542
Previous 2,452,283 3.11%
Holding current value
$227 Million
Previous $168 Million 25.97%
% of portfolio
0.07%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$66.59 - $83.99 $5.08 Million - $6.4 Million
76,259 Added 3.11%
2,528,542 $212 Million
Q2 2024

Aug 08, 2024

SELL
$63.15 - $72.88 $3.47 Million - $4 Million
-54,929 Reduced 2.19%
2,452,283 $168 Million
Q1 2024

May 13, 2024

BUY
$71.58 - $87.29 $5.98 Million - $7.29 Million
83,479 Added 3.44%
2,507,212 $184 Million
Q4 2023

Feb 13, 2024

SELL
$73.27 - $83.09 $12.4 Million - $14.1 Million
-169,506 Reduced 6.54%
2,423,733 $196 Million
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $36.4 Million - $39.7 Million
492,471 Added 23.44%
2,593,239 $194 Million
Q2 2023

Aug 04, 2023

SELL
$76.01 - $86.7 $345 Million - $394 Million
-4,542,171 Reduced 68.38%
2,100,768 $162 Million
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $303 Million - $345 Million
3,915,348 Added 143.55%
6,642,939 $551 Million
Q4 2022

Feb 07, 2023

BUY
$62.32 - $89.47 $8.07 Million - $11.6 Million
129,435 Added 4.98%
2,727,591 $234 Million
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $11.1 Million - $12.7 Million
186,332 Added 7.73%
2,598,156 $160 Million
Q2 2022

Aug 03, 2022

BUY
$57.72 - $65.01 $12.8 Million - $14.5 Million
222,391 Added 10.16%
2,411,824 $149 Million
Q1 2022

May 04, 2022

BUY
$57.92 - $72.58 $9.3 Million - $11.6 Million
160,481 Added 7.91%
2,189,433 $130 Million
Q4 2021

Feb 04, 2022

BUY
$64.88 - $73.64 $4.78 Million - $5.43 Million
73,714 Added 3.77%
2,028,952 $147 Million
Q3 2021

Oct 07, 2021

SELL
$67.69 - $73.03 $1.83 Million - $1.98 Million
-27,069 Reduced 1.37%
1,955,238 $137 Million
Q2 2021

Aug 04, 2021

BUY
$63.47 - $69.35 $16 Million - $17.5 Million
252,245 Added 14.58%
1,982,307 $137 Million
Q1 2021

May 04, 2021

BUY
$60.0 - $68.46 $22.8 Million - $26 Million
380,145 Added 28.16%
1,730,062 $112 Million
Q4 2020

Feb 02, 2021

BUY
$56.65 - $64.55 $2.67 Million - $3.04 Million
47,061 Added 3.61%
1,349,917 $78.6 Million
Q3 2020

Oct 09, 2020

BUY
$62.1 - $78.08 $16.1 Million - $20.2 Million
258,483 Added 24.75%
1,302,856 $82.3 Million
Q2 2020

Jul 08, 2020

SELL
$72.34 - $84.0 $18.4 Million - $21.4 Million
-254,686 Reduced 19.61%
1,044,373 $80.4 Million
Q1 2020

Apr 23, 2020

BUY
$62.63 - $80.22 $774,670 - $992,241
12,369 Added 0.96%
1,299,059 $97.1 Million
Q4 2019

Feb 11, 2020

BUY
$61.62 - $67.78 $2.89 Million - $3.18 Million
46,899 Added 3.78%
1,286,690 $83.6 Million
Q3 2019

Oct 17, 2019

BUY
$62.51 - $69.0 $29.3 Million - $32.4 Million
468,935 Added 60.83%
1,239,791 $78.6 Million
Q2 2019

Aug 02, 2019

SELL
$61.87 - $69.38 $1.94 Million - $2.17 Million
-31,327 Reduced 3.91%
770,856 $52.1 Million
Q1 2019

May 10, 2019

BUY
$62.53 - $70.05 $5.06 Million - $5.67 Million
80,890 Added 11.21%
802,183 $52.2 Million
Q4 2018

Feb 13, 2019

BUY
$60.54 - $79.0 $30.9 Million - $40.3 Million
510,704 Added 242.51%
721,293 $45.1 Million
Q3 2018

Nov 14, 2018

SELL
$71.28 - $78.92 $26.7 Million - $29.6 Million
-375,228 Reduced 64.05%
210,589 $16.3 Million
Q2 2018

Aug 10, 2018

BUY
$64.88 - $75.68 $32.5 Million - $37.9 Million
500,802 Added 589.07%
585,817 $41.5 Million
Q1 2018

May 09, 2018

SELL
$72.84 - $88.8 $38.8 Million - $47.3 Million
-533,087 Reduced 86.25%
85,015 $6.35 Million
Q4 2017

Feb 20, 2018

SELL
$71.15 - $83.52 $235,364 - $276,284
-3,308 Reduced 0.53%
618,102 $44.3 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $775,831 - $919,571
10,759 Added 1.76%
621,410 $50.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
610,651
610,651 $43.2 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.